Clinical Trials 
BMT Clinical Trials - Updated August 15, 2010
- NSH 721 – NMDP Recipient Consent for Participation in Registry, Research Database, and Research Sample Repository
- NSH 756 – Reduced Intensity Allogeneic Stem Cell Transplantation with Matched Unrelated Donors for Patients with Hematologic Malignances
- NSH 810 – A Phase II Study of Allogeneic Transplant for Older Patients with AML in First Morphologic Complete Remission Using a Non-Myeloblative Preparative Regimen; CALGB 100103/BMT CTN 0502
- NSH 864 – A Phase II trial of Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients with Hematologic Malignancies
- NSH 877 – A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy
- NSH 886 – A Randomized, double-blind, placebo-controlled Phase III study of SGN-35 (brentuximab vedotin) and BSC versus placebo and BSC in the treatment of patients at high risk for residual HL following ASCT
- NSH 887 – A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with MMF vs Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD
- NSH 888 – The Impact of Hematopoietic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
- NSH 894 – A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma; BMT CTN Protocol 0702
Leukemia Clinical Trials - Updated August 15, 2010
- NSH 825 – A Phase I/II Trial of the Combination Vidaza and Mylotarg Therapy for Treatment of Relapsed AML
- NSH 850 – Phase III Open-Label Randomized Study of Amonafide L-Malate in Combination with Cytarabine compared to Daunorubicin in Combination with Cytarabine in Patients with Secondary AML
